Emerging viral respiratory tract infections—environmental risk factors and transmission
| dc.contributor.author | Gautret, Philippe | |
| dc.contributor.author | Gray, Gregory C. | |
| dc.contributor.author | Charrel, Remi N. | |
| dc.contributor.author | Odezulu, Nnanyelugo G. | |
| dc.contributor.author | Al-Tawfiq, Jaffar A. | |
| dc.contributor.author | Zumla, Alimuddin | |
| dc.contributor.author | Memish, Ziad A. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2020-04-27T20:16:07Z | |
| dc.date.available | 2020-04-27T20:16:07Z | |
| dc.date.issued | 2014-11 | |
| dc.description | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | |
| dc.description.abstract | The past decade has seen the emergence of several novel viruses that cause respiratory tract infections in human beings, including Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia, an H7N9 influenza A virus in eastern China, a swine-like influenza H3N2 variant virus in the USA, and a human adenovirus 14p1 also in the USA. MERS-CoV and H7N9 viruses are still a major worldwide public health concern. The pathogenesis and mode of transmission of MERS-CoV and H7N9 influenza A virus are poorly understood, making it more difficult to implement intervention and preventive measures. A united and coordinated global response is needed to tackle emerging viruses that can cause fatal respiratory tract infections and to fill major gaps in the understanding of the epidemiology and transmission dynamics of these viruses. | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Gautret, P., Gray, G. C., Charrel, R. N., Odezulu, N. G., Al-Tawfiq, J. A., Zumla, A., & Memish, Z. A. (2014). Emerging viral respiratory tract infections—environmental risk factors and transmission. The Lancet Infectious Diseases, 14(11), 1113-1122. https://doi.org/10.1016/S1473-3099(14)70831-X | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/22655 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/S1473-3099(14)70831-X | en_US |
| dc.relation.journal | The Lancet Infectious Diseases | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.rights | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | |
| dc.source | Publisher | en_US |
| dc.subject | viral respiratory infections | en_US |
| dc.subject | Middle East Respiratory Syndrome Coronavirus | en_US |
| dc.subject | respiratory viruses | en_US |
| dc.title | Emerging viral respiratory tract infections—environmental risk factors and transmission | en_US |
| dc.type | Article | en_US |